Workflow
Immunology treatments
icon
Search documents
Why Bristol-Myers Squibb (BMY) Deserves a Spot in Passive Income Portfolios
Yahoo Finance· 2025-09-28 01:07
Bristol-Myers Squibb Company (NYSE:BMY) is included among the 12 Best Stocks to Buy Now for Passive Income.  Why Bristol-Myers Squibb (BMY) Deserves a Spot in Passive Income Portfolios Bristol-Myers Squibb Company (NYSE:BMY) is a global biopharmaceutical company that many consider worth investing in and holding long-term. Its history dates back to the early 1800s, shaped by decades of drug innovation and strategic mergers. Today, the company focuses on treatments in oncology, cardiovascular health, immun ...
AbbVie: Q1 Earnings Reinforce Positive Momentum
Seeking Alpha· 2025-04-25 20:00
Group 1 - AbbVie Inc. (NYSE: ABBV) has experienced a share price increase of 1.7% during the trading session, indicating positive investor sentiment [1] - The potential for further price appreciation exists as investor confidence remains high [1] Group 2 - Manika, a macroeconomist with over 20 years of experience, is involved in investment management and focuses on opportunities in the green economy through her investing group, Green Growth Giants [1]